We are live on ! Find out more
CHRS icon

Coherus Oncology
CHRS

86 hedge funds and large institutions have $428M invested in Coherus Oncology in 2016 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 43 increasing their positions, 10 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

330% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 10

109% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 11

15% more funds holding

Funds holding: 75 → 86 (+11)

11% more capital invested

Capital invested by funds: $385M → $428M (+$43.2M)

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

95% less call options, than puts

Call options by funds: $21K | Put options by funds: $432K

Holders
86
Holders Change
+11
Holders Change %
+14.67%
% of All Funds
2.29%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
23
Increased
43
Reduced
10
Closed
11
Calls
$21K
Puts
$432K
Net Calls
-$411K
Net Calls Change
-$498K

Top Buyers

Rank Fund Capital Flow
1
KKRC
Kohlberg Kravis Roberts & Co
New York
+$57.4M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$33M
3
Citadel Advisors
Citadel Advisors
Florida
+$12.7M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$9.96M
5
Millennium Management
Millennium Management
New York
+$7.53M

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$27M
2
BM
Bridger Management
New York
-$7.24M
3
JP Morgan Chase
JP Morgan Chase
New York
-$4.61M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1.76M
5
EAM
EverPoint Asset Management
Connecticut
-$1.06M
Name Holding Trade Value Shares
Change 		Change in
Stake
TA
26
Teachers Advisors
New York
$2.47M +$224K +11,942 +9%
EAM
27
Eventide Asset Management
Massachusetts
$2.45M – – –
Bank of New York Mellon
28
Bank of New York Mellon
New York
$2.33M +$688K +36,650 +36%
RPAM
29
Rhenman & Partners Asset Management
Sweden
$2.22M +$2.47M +131,357 New
TI
30
Turner Investments
Pennsylvania
$2.04M +$2.27M +120,850 New
BIM
31
BlackRock Investment Management
Delaware
$1.93M +$567K +30,179 +36%
Macquarie Group
32
Macquarie Group
Australia
$1.88M +$2.09M +111,110 New
LOAMS
33
Lombard Odier Asset Management (Switzerland)
Switzerland
$1.85M +$2.06M +109,664 New
Charles Schwab
34
Charles Schwab
California
$1.8M +$1.04M +55,566 +109%
Renaissance Technologies
35
Renaissance Technologies
New York
$1.6M +$1.77M +94,500 New
IHM
36
Iguana Healthcare Management
New York
$1.27M -$469K -25,000 -25%
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$1.04M +$223K +11,902 +24%
Deutsche Bank
38
Deutsche Bank
Germany
$788K +$742K +39,512 +543%
Allianz Asset Management
39
Allianz Asset Management
Germany
$781K +$868K +46,259 New
Handelsbanken Fonder
40
Handelsbanken Fonder
Sweden
$760K -$188K -10,000 -18%
OAM
41
Oxford Asset Management
United Kingdom
$729K +$810K +43,157 New
CS
42
Credit Suisse
Switzerland
$659K +$208K +11,090 +40%
Point72 Asset Management
43
Point72 Asset Management
Connecticut
$633K -$1.76M -93,700 -71%
Swiss National Bank
44
Swiss National Bank
Switzerland
$630K +$160K +8,500 +30%
NFA
45
Nationwide Fund Advisors
Ohio
$616K +$408K +21,713 +147%
AllianceBernstein
46
AllianceBernstein
Tennessee
$556K +$88.2K +4,700 +17%
ProShare Advisors
47
ProShare Advisors
Maryland
$553K +$17.1K +912 +3%
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
$510K +$131K +7,000 +30%
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$483K +$113K +6,036 +27%
Franklin Resources
50
Franklin Resources
California
$422K – – –
1
2
3 4

CHRS Hedge Fund Activity: Q2 2016 in Review

86 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Coherus Oncology (CHRS) for Q2 2016, worth a combined $428M — up 11% from $385M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new CHRS positions and 11 closed out — a net gain of 12 holders — while 43 added to existing stakes and 10 trimmed.

The largest buyer was Kohlberg Kravis Roberts & Co, opening a new position worth an estimated $57.4M. The largest seller was RA Capital Management, exiting entirely with an estimated $27M sold.

  • 86 institutional investors held Coherus Oncology (CHRS) as of Q2 2016, up from 75 in Q1 2016.
  • Funds reported $428M of Coherus Oncology stock for Q2 2016, up 11% quarter-over-quarter.
  • 23 funds opened new Coherus Oncology positions in Q2 2016 and 11 closed out, a net change of +12 holders.
  • The largest Coherus Oncology buyer in Q2 2016 was Kohlberg Kravis Roberts & Co, an estimated $57.4M added.
  • The largest Coherus Oncology seller in Q2 2016 was RA Capital Management, an estimated $27M sold.

Based on aggregated 13F filings for Q2 2016.